Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: determined (252), resolute (3)

SOP setting up a new trial as a centre

Description: Paediatric Oncology UHSStandard Operating ProcedureProcedure for The Setting Up Of A New Trial (As A Centre)SOP Number: Ve
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/POSCU/SOP-Setting-up-a-New-Trial-As-a-Centre.pdf

Sexual function after radical cystectomy - Information for women - patient information

Description: This factsheet explains how a radical cystectomy can affect sexual function and ways to help manage these changes.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Sexual-function-after-radical-cystectomy-Information-for-women-3743-PIL.pdf

Cisplatin-Lomustine-Vincristine (Packer LCV3)

Description: Chemotherapy Protocol Central Nervous System CISPLATIN-LOMUSTINE-VINCRISTINE (Packer LCV3) Regimen • CNS – Cisplatin-Lomustine-Vin
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Cisplatin-Lomustine-Vincristine-Packer-LCV3.pdf

Neonatal jaundice - patient information

Description: This factsheet explains what neonatal jaundice is, the signs to look out for and how it is treated.
Url: /Media/UHS-website-2019/Patientinformation/Neonatal/Neonatal-jaundice-3680-PIL.pdf

Anti-VEGF injection treatment - patient information

Description: You have been given this factsheet because your doctor has recommended anti-VEGF injection treatment for your eye condition.
Url: /Media/UHS-website-2019/Patientinformation/Eyes/Anti-VEGF-injection-treatment-1331-PIL.pdf

Lutetium-177 prostate specific membrane antigen (PSMA) therapy - patient information

Description: This factsheet explains what Lutetium-177 prostate specific membrane antigen (PSMA) therapy is, what the therapy involves, and what the possible
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Lutetium-177-prostate-specific-membrane-antigen-PSMA-therapy-2881-PIL.pdf

InP-Cisplatin-Etoposide-Ifosfamide (VIP)

Description: Chemotherapy Protocol GERM CELL CISPLATIN-ETOPOSIDE-IFOSFAMIDE (VIP) Inpatient Regimen Regimen • Germ Cell – InP-Cisplatin-Eto
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Cisplatin-Etoposide-Ifosfamide-VIP.pdf

Bevacizumab(15mgkg) Carboplatin Gemcitabine (day1)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1) This protocol may require
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkg-Carboplatin-Gemcitabine-day1.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this pro
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Your stay at the major trauma centre - patient information

Description: This factsheet gives you useful information about your stay at the major trauma centre.
Url: /Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Your-stay-at-the-major-trauma-centre-3125-PIL.pdf

371 to 380 of 496

Previous … 36 37 38 39 40 … Next